Integral Diagnostics Limited
ASX: IDX
Scale driven momentum meets ageing population tailwinds.
(Source: TradingView) 3-Month Performance Profile of IDX on a DTF compared to S&P/ASX 200 (XJO).
FY25 marked a solid step up for IDX, with operating income rising 36.35% YoY. As Australia’s one of largest pure-play listed radiology network, the company benefits from structural advantages such as f
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
